Selwyn Vickers: MSK has launched ‘The MSK Campaign: Leading Science. Changing Lives’
Selwyn Vickers, President and CEO of Memorial Sloan Kettering Cancer Center, shared on LinkedIn:
“Every day, we move closer to realizing Memorial Sloan Kettering Cancer Center’s mission of ending cancer for life. It happens one patient and one life-changing discovery at a time. Fueled by the innovation and compassion of our staff, it’s a mission driven by our ambition and collective hope that one day we will see a world where cancer is no longer a threat but a chapter in history.
Propelling this work requires support. For this reason, MSK has launched ‘The MSK Campaign: Leading Science. Changing Lives’, a comprehensive, focused effort to identify and secure funding for MSK’s critical patient care and research initiatives, which is co-chaired by Scott Stuart, Chair of the Board of Trustees; Marie-Josée Kravis, Vice Chair of the Board; and Stanley Freeman Druckenmiller, Trustee.
With the support garnered through The MSK Campaign, we will enable better treatments, more cures, and access to cutting-edge care. Together, we will build the future we envision.”
View additional information.
Source: Selwyn Vickers/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023